本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Syndax Pharmaceuticals, Inc.

18.18
-0.6400-3.40%
盤後18.05-0.1300-0.72%19:30 EDT
成交量:122.33萬
成交額:2,239.28萬
市值:16.23億
市盈率:-7.24
高:19.02
開:19.01
低:18.02
收:18.82
52周最高:25.59
52周最低:12.99
股本:8,929.71萬
流通股本:8,029.50萬
量比:0.83
換手率:1.52%
股息:- -
股息率:- -
每股收益(TTM):-2.5100
每股收益(LYR):-3.2949
淨資產收益率:-255.93%
總資產收益率:-18.67%
市淨率:107.52
市盈率(LYR):-5.52

資料載入中...

2021/05/03

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/30

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/20

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/12

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/08

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

重要事件披露

8-K - Current report
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/21

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/09

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/02

重要事件披露

8-K - Current report